Tuberculosis

Introducing fast and accurate tests where patients seek care

Neglected tropical diseases (NTDs)

Contributing to elimination through new and improved tests

Malaria & Acute febrile syndrome (AFS)

Assuring quality of existing rapid tests and developing new tools

Access

Projects reach important milestones

  • 1
  • 2
  • 3
  • 4

Latest News

Update on Ebola: relevance of diagnostics for urgent and sustained disease control

30 October 2014

Situational review of Ebola diagnostics and opportunities for rapid improvement

Collaboration for next-generation innovations to game-changing Xpert MTB/RIF

28 October 2014

Cepheid, FIND, and Rutgers New Jersey Medical School today announced details of a collaboration to develop Xpert® MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection. The collaboration is also receiving additional support from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

FIND and QuantuMDx to develop breakthrough technology for tuberculosis detection and drug resistance determination

28 October 2014

FIND and QuantuMDx Group, a British medical device developer, have joined forces to develop a paradigm-changing solution for the combined detection of tuberculosis and drug susceptibility determination for the causative agent of tuberculosis. The simple handheld device developed by QuantuMDx will reduce the time for antimycobacterial resistance profiling from weeklong to less than half an hour.

FIND launches ‘Support for Success’ programme to accelerate delivery of innovative TB diagnostics

28 October 2014

FIND is strengthening the diagnostics landscape through its new ‘Support for Success’ (S4S) initiative, which will spur the development and uptake of promising fit-for-purpose diagnostics in low-resource countries. Molbio Diagnostics Pvt. Ltd. of India is the first partner in the S4S programme, with FIND providing technical assistance and resources in the development of a next generation molecular platform for tuberculosis diagnosis.

right column